0001104659-23-084974.txt : 20230728
0001104659-23-084974.hdr.sgml : 20230728
20230728061120
ACCESSION NUMBER: 0001104659-23-084974
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230727
FILED AS OF DATE: 20230728
DATE AS OF CHANGE: 20230728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glickman Mark A
CENTRAL INDEX KEY: 0001441461
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 231120090
MAIL ADDRESS:
STREET 1: C/O ESPERION THERAPEUTICS, INC.
STREET 2: 3891 RANCHERO DRIVE, SUITE 150
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY ST.
STREET 2: FL 19
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (857) 702-9600
MAIL ADDRESS:
STREET 1: 200 BERKELEY ST.
STREET 2: FL 19
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Gemphire Therapeutics Inc.
DATE OF NAME CHANGE: 20150331
4
1
tm2321997-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-07-27
0
0001638287
NeuroBo Pharmaceuticals, Inc.
NRBO
0001441461
Glickman Mark A
C/O NEUROBO PHARMACEUTICALS, INC.
200 BERKELEY STREET, OFFICE 19TH FLOOR
BOSTON
MA
02116
1
0
0
0
0
Common Stock
2023-07-27
4
A
0
25000
0
A
25000
D
Common Stock
2023-07-27
4
A
0
12500
0
A
37500
D
Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan.
50% of the RSUs vested immediately, and the remainder will vest in two equal installments on each subsequent anniversary of the date of grant, subject to continuing service.
Vests on the earlier of July 27, 2024 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service.
/s/ Phillip D. Torrence, by Power of Attorney
2023-07-28